Literature DB >> 11280949

Oncologists' opinions on genetic testing for breast and ovarian cancer.

J O Culver1, J L Hull, D F Dunne, W Burke.   

Abstract

PURPOSE: To determine oncologists' practices and beliefs about genetic testing for hereditary breast and ovarian cancer and the extent to which oncologists are utilizing clinical genetics services.
METHODS: A survey was mailed to oncologists who treat adult patients in Washington, Oregon, Idaho, or Alaska.
RESULTS: Most oncologists (79%) had discussed genetic tests with their patients, and 76% indicated they would like patients considering genetic testing to consult with a genetic counselor. Yet few (19%) indicated their medical practice had the necessary services and staff to offer genetic testing, and only 11% had made referrals to medical genetics or genetic counselors.
CONCLUSION: Most respondents support the use of genetic services, but few have made referrals to genetic counselors. Increased communication between oncologists and genetic counselors may enhance collaboration between these two disciplines.

Entities:  

Mesh:

Year:  2001        PMID: 11280949     DOI: 10.1097/00125817-200103000-00006

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  4 in total

1.  Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.

Authors:  Terri Febbraro; Katina Robison; Jennifer Scalia Wilbur; Jessica Laprise; Amy Bregar; Vrishali Lopes; Robert Legare; Ashley Stuckey
Journal:  Gynecol Oncol       Date:  2015-04-28       Impact factor: 5.482

Review 2.  Clinical cancer genomic profiling.

Authors:  Debyani Chakravarty; David B Solit
Journal:  Nat Rev Genet       Date:  2021-03-24       Impact factor: 53.242

3.  Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.

Authors:  Ian Teng; Allan Spigelman
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

4.  Health care providers and direct-to-consumer access and advertising of genetic testing in the United States.

Authors:  Melanie F Myers
Journal:  Genome Med       Date:  2011-12-28       Impact factor: 15.266

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.